Immucor Acquires Gamma Biologicals

	Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
	Immucor retained TM Capital as financial advisor to assist in an acquisition program which would build the company's position in the transfusion diagnostics marketplace
	TM Capital assisted Immucor in negotiating the acquisition of Gamma Biologicals, Inc. (AMEX: GBL) for $30 million via a cash tender offer for which TM Capital also served as dealer manager